Protalix BioTherapeutics
PLX
#8340
Rank
A$0.29 B
Marketcap
A$3.73
Share price
-5.76%
Change (1 day)
0.36%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): A$0.02312

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is A$0.02844. In 2024 the company made an earnings per share (EPS) of A$0.05688 a decrease over its 2023 EPS that were of A$0.17.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$0.02312-59.36%
2024A$0.05688-66.67%
2023A$0.17-138.71%
2022A-$0.44-50%
2021A-$0.88181.82%
2020A-$0.31-82.11%
2019A-$1.75-31.67%
2018A-$2.56-72.31%
2017A-$9.24124.14%
2016A-$4.12-147.54%
2015A$8.67-290.63%
2014A-$4.556.67%
2013A-$4.27130.77%
2012A-$1.85-69.77%
2011A-$6.1119.44%
2010A-$5.12-12.2%
2009A-$5.8336.67%
2008A-$4.27-37.5%
2007A-$6.8350%
2006A-$4.553.23%
2005A-$4.41138.46%
2004A-$1.85-74%
2003A-$7.11-0%
2002A-$7.11-50%
2001A-$14.22233.33%
2000A-$4.27-84.21%
1999A-$27.02-24%
1998A-$35.55-600%
1997A$7.11-16.67%
1996A$8.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.93 6,700.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$6.13 21,450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A-$0.16-650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$1.76 6,100.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel